-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-135-fullreport.pdf
February 01, 2017 - Timeliness of Antibiotic Prophylaxis for Children With Sickle Cell Disease
Timeliness of Antibiotic Prophylaxis for Children
with Sickle Cell Disease
Section 1. Basic Measure Information
1.A. Measure Name
Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease
1.B. Measure Number
0135
…
-
www.monahrq.ahrq.gov/hai/tools/ambulatory-surgery/sections/implementation/training-tools/improving-fac-notes.html
May 01, 2017 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
www.monahrq.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/final-report/section2.html
October 01, 2015 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-fullreport.pdf
February 01, 2019 - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics
1
Use of First-Line Psychosocial Care for Children and
Adolescents on Antipsychotics
Section 1. Basic Measure Information
1.A. Measure Name
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics
1.B.…
-
www.monahrq.ahrq.gov/sites/default/files/publications/files/chipra-final-report_0.pdf
February 21, 2016 - National Evaluation of the CHIPRA Quality Demonstration Grant Program: Final Project Report
Contract Final Report
National Evaluation of the CHIPRA Quality
Demonstration Grant Program: Final Project Report
Prepared for:
Agency for Healthcare Research and Quality
Rockville, MD
Contract HHSA29020090002191
…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Table 5.A.1. Evidence Table
…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-170-fullreport.pdf
April 01, 2016 - Prenatal Care Screening
Prenatal Care Screening
Section 1. Basic Measure Information
1.A. Measure Name
Prenatal Care Screening
1.B. Measure Number
0170
1.C. Measure Description
Please provide a non-technical description of the measure that conveys what it measures to
a broad audience.
This measure assesses …
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0084-fullreport.pdf
March 01, 2016 - Postpartum Followup and Care Coordination
Postpartum Followup and Care Coordination
Section 1. Basic Measure Information
1.A. Measure Name
Postpartum Followup and Care Coordination
1.B. Measure Number
0084
1.C. Measure Description
Please provide a non-technical description of the measure that conveys what it …
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/g2_combo_specifictoolstosupportchange.pdf
January 01, 2011 - Specific Tools To Support Change
Toolkit for Using the AHRQ Quality Indicators
How To Improve Hospital Quality and Safety
i Tool G.2
Specific Tools To Support Change
What is the purpose of this tool? This tool provides information on tools developed by other
organizations that may be used instead of or …
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0085-fullreport.pdf
December 31, 2015 - Behavioral Health Risk Assessment
Behavioral Health Risk Assessment
Section 1. Basic Measure Information
1.A. Measure Name
Behavioral Health Risk Assessment
1.B. Measure Number
0085
1.C. Measure Description
Please provide a non-technical description of the measure that conveys what it measures to
a broad …
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0082-fullreport.pdf
March 01, 2016 - Cesarean Delivery for Nulliparous (NTSV) Women (Appropriate Use)
Cesarean Delivery for Nulliparous (NTSV) Women
(Appropriate Use)
Section 1. Basic Measure Information
1.A. Measure Name
Cesarean Delivery for Nulliparous (NTSV) Women (Appropriate Use)
1.B. Measure Number
0082
1.C. Measure Description
Please…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-0083-fullreport.pdf
March 01, 2016 - Episiotomy (Overuse): Report
Episiotomy (Overuse)
Section 1. Basic Measure Information
1.A. Measure Name
Episiotomy (Overuse)
1.B. Measure Number
0083
1.C. Measure Description
Please provide a non-technical description of the measure that conveys what it measures to
a broad audience.
This measur…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0138-fullreport.pdf
April 01, 2018 - Appropriate Antibiotic Prophylaxis for Children With Sickle Cell Disease
1
Appropriate Antibiotic Prophylaxis for Children with
Sickle Cell Disease
Section 1. Basic Measure Information
1.A. Measure Name
Appropriate Antibiotic Prophylaxis for Children with Sickle Cell Disease
1.B. Measure Number
0138
1.C…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/invest-in-trust-guide.pdf
May 01, 2021 - Invest in Trust: A Guide for Building COVID-19 Vaccine Trust and Increasing Vaccination Rates Among CNAs
A Guide for Building COVID-19
Vaccine Trust and Increasing
Vaccination Rates Among CNAs
Invest
Trustin
2
Contents
Introduction 3
Summary 4
Section 1: How We Approached This Project 6
Section 2: What Is …